These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33480206)

  • 1. The Expanded Disability Status Scale Score and Demographic Indexes Are Correlated with the Severity of Cognitive Impairment in Multiple Sclerosis Patients.
    Sadigh-Eteghad S; Abbasi Garravnd N; Feizollahi M; Talebi M
    J Clin Neurol; 2021 Jan; 17(1):113-120. PubMed ID: 33480206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
    Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
    Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
    Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder.
    Rezaeimanesh N; Saeedi R; Sahraian MA; Ghadiri F; Naser Moghadasi A
    Curr J Neurol; 2022 Apr; 21(2):74-82. PubMed ID: 38011484
    [No Abstract]   [Full Text] [Related]  

  • 5. Demographic features, behavioral measures, and clinical factors as predictors of cognitive function in patients with multiple sclerosis.
    Alirezaei M; Forouzannia SM; Yarahmadi P; Sahraian MA; Owji M; Bidadian M; Ghadiri F; Naser Moghadasi A
    Mult Scler Relat Disord; 2021 Apr; 49():102758. PubMed ID: 33567391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between cognitive function and body mass index in multiple sclerosis patients.
    Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
    Bogaardt H; Golan D; Barrera MA; Attrill S; Kaczmarek O; Zarif M; Bumstead B; Buhse M; Wilken J; Doniger GM; Hancock LM; Penner IK; Halper J; Morrow SA; Covey TJ; Gudesblatt M
    Mult Scler Relat Disord; 2023 May; 73():104630. PubMed ID: 36965219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients.
    El-Salem K; Al-Mistarehi AH; Hanan Khalil ; Alham Al-Sharman ; Yassin A
    Mult Scler Relat Disord; 2021 Jan; 47():102621. PubMed ID: 33197871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a predominant cognitive phenotype in patients with multiple sclerosis.
    Zurawski J; Healy BC; Ratajska A; Barker L; Glanz BI; Houtchens M
    Eur J Neurol; 2020 Jun; 27(6):1083-1088. PubMed ID: 32080929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
    Nelson F; Akhtar MA; Zúñiga E; Perez CA; Hasan KM; Wilken J; Wolinsky JS; Narayana PA; Steinberg JL
    Mult Scler; 2017 May; 23(6):836-847. PubMed ID: 27613119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study.
    Nunnari D; De Cola MC; Costa A; Rifici C; Bramanti P; Marino S
    J Clin Exp Neuropsychol; 2016 Dec; 38(10):1158-67. PubMed ID: 27410680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and cognitive functions in early onset multiple sclerosis.
    Lanzillo R; Chiodi A; Carotenuto A; Magri V; Napolitano A; Liuzzi R; Costabile T; Rainone N; Freda MF; Valerio P; Brescia Morra V
    Eur J Paediatr Neurol; 2016 Jan; 20(1):158-63. PubMed ID: 26387071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.
    Gajofatto A; Turatti M; Bianchi MR; Forlivesi S; Gobbin F; Azzarà A; Monaco S; Benedetti MD
    Acta Neurol Scand; 2016 Mar; 133(3):183-91. PubMed ID: 26009804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.